Insider Transactions in Q3 2023 at Turnstone Biologics Corp. (TSBX)
Insider Transaction List (Q3 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 25
2023
|
Davis Jerel |
BUY
Open market or private purchase
|
Indirect |
225,000
+6.75%
|
$2,700,000
$12.0 P/Share
|
|
Jul 25
2023
|
Davis Jerel |
BUY
Conversion of derivative security
|
Indirect |
3,156,692
+50.0%
|
-
|
|
Jul 25
2023
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
225,000
+6.75%
|
$2,700,000
$12.0 P/Share
|
|
Jul 25
2023
|
Versant Ventures V, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
3,156,692
+50.0%
|
-
|
|
Jul 25
2023
|
Fmr LLC |
BUY
Conversion of derivative security
|
Indirect |
1,133,987
+41.98%
|
-
|
|
Jul 20
2023
|
Rishi Gupta |
BUY
Open market or private purchase
|
Indirect |
416,666
+11.85%
|
$4,999,992
$12.0 P/Share
|
|
Jul 20
2023
|
Rishi Gupta |
BUY
Conversion of derivative security
|
Indirect |
2,682,599
+50.0%
|
-
|
|
Jul 20
2023
|
Orbimed Advisors LLC Director |
BUY
Open market or private purchase
|
Indirect |
416,666
+11.85%
|
$4,999,992
$12.0 P/Share
|
|
Jul 20
2023
|
Orbimed Advisors LLC Director |
BUY
Conversion of derivative security
|
Indirect |
2,682,599
+50.0%
|
-
|